UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): October 27, 2023
EDOC Acquisition Corp.
(Exact
name of registrant as specified in its charter)
| Cayman Islands |
|
001-39689 |
|
N/A |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
7612 Main Street Fishers
Suite 200
Victor,
NY 14564
(Address
of principal executive offices, including zip code)
Registrant’s
telephone number, including area code: (585) 678-1198
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☒ |
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Class A Ordinary Shares, $.0001 par value per share |
|
ADOC |
|
The Nasdaq Stock Market
LLC |
| Rights, exchangeable into one-tenth of one Class A Ordinary Share |
|
ADOCR |
|
The Nasdaq Stock Market
LLC |
| Warrants, each exercisable for one-half of one Class A Ordinary Share, each whole Warrant exercisable for $11.50 per share |
|
ADOCW |
|
The Nasdaq Stock Market
LLC |
Item
1.01 Entry into a Material Definitive Agreement.
As
previously disclosed by Edoc Acquisition Corp., a special purpose acquisition company formed as a Cayman Islands exempted company (together
with its successors, “Edoc” or “Company”), on December 5, 2022, Edoc entered into Business Combination
Agreement (as amended on March 31, 2023, and as may be further amended or supplemented from time to time, the “Business Combination
Agreement”) with Australian Oilseeds Investments Pty Ltd., an Australian proprietary company (the “AOI”),
Australian Oilseeds Holdings Limited, a Cayman Islands exempted company (“Pubco”), AOI Merger Sub, Cayman Islands
exempted company and a wholly-owned subsidiary of Pubco (“Merger Sub”), American Physicians LLC, a Delaware limited
liability company (“Purchaser Representative”), in the capacity as the Purchaser Representative thereunder, and Gary
Seaton, in his capacity as the representative for the Sellers (as defined below) in accordance with the terms and conditions of the Business
Combination Agreement (the “Seller Representative”).
On
October 27, 2023, Edoc, Pubco and Continental Stock Transfer & Trust Company (“Continental”) entered into an Assignment,
Assumption and Amendment Agreement (the “Warrant Assumption Agreement”), which amends that certain Warrant Agreement,
dated as of November 9, 2020 (as amended, the “Warrant Agreement”), by and between Edoc and Continental, as warrant
agent, such that, among other items, Edoc assigns all of its right, title and interest in the Warrant Agreement to Pubco, upon the Merger
Effective Time (as defined in the Warrant Assumption Agreement) and Pubco assumes and agrees to fulfill all of Edoc’s liabilities
and obligations under the Warrant Agreement arising from and after the Merger Effective Time.
The
foregoing summary of the Warrant Assumption Agreement is qualified in its entirety by reference to the full text of the
form of Warrant Assumption Agreement, which is attached as Exhibit 10.1 hereto and the terms of which are incorporated
herein by reference.
Item
8.01 Other Events.
On
October 27, 2023, the Sponsor and Pubco entered into a share transfer agreement (the “Share Transfer Agreement”), pursuant
to which the Sponsor agreed to transfer to Pubco, on the date of the closing of the Business Combination (as defined below), 200,000
ordinary shares of Pubco, par value $0.0001 per share to be received pursuant to the transactions contemplated by the Business Combination
(the “Business Combination”).
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
Forward-Looking
Statements
The
information in this report includes “forward-looking statements” within the meaning of the “safe harbor” provisions
of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words
such as “estimate,” “plan,” “project,” “forecast,” “intend,” “may,”
“will,” “expect,” “continue,” “should,” “would,” “anticipate,”
“believe,” “seek,” “target,” “predict,” “potential,” “seem,”
“future,” “outlook” or other similar expressions that predict or indicate future events or trends or that are
not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking
statements include, but are not limited to, (1) statements regarding estimates and forecasts of financial and performance metrics and
projections of market opportunity and market share; (2) references with respect to the anticipated benefits of the proposed Business
Combination and the projected future financial performance of Edoc and AOI’s operating companies following the proposed Business
Combination; (3) changes in the market for AOI’s products and services and expansion plans and opportunities; (4) AOI’s unit
economics; (5) the sources and uses of cash of the proposed Business Combination; (6) the anticipated capitalization and enterprise value
of the combined company following the consummation of the proposed Business Combination; (7) the projected technological developments
of AOI and its competitors; (8) anticipated short- and long-term customer benefits; (9) current and future potential commercial and customer
relationships; (10) the ability to manufacture efficiently at scale; (11) anticipated investments in research and development and the
effect of these investments and timing related to commercial product launches; and (12) expectations related to the terms and timing
of the proposed Business Combination. These statements are based on various assumptions, whether or not identified in this report, and
on the current expectations of AOI’s and Edoc’s management and are not predictions of actual performance. These forward-looking
statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as,
a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult
or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of AOI and Edoc.
These forward-looking statements are subject to a number of risks and uncertainties, including the occurrence of any event, change or
other circumstances that could give rise to the termination of the Business Combination Agreement; the risk that the Business Combination
disrupts current plans and operations as a result of the announcement and consummation of the transactions described herein; the inability
to recognize the anticipated benefits of the Business Combination; the ability to obtain or maintain the listing of the Pubco’s
securities on The Nasdaq Stock Market, following the Business Combination, including having the requisite number of shareholders; costs
related to the Business Combination; changes in domestic and foreign business, market, financial, political and legal conditions; risks
relating to the uncertainty of the projected financial information with respect to AOI; AOI’s ability to successfully and timely
develop, manufacture, sell and expand its technology and products, including implement its growth strategy; AOI’s ability to adequately
manage any supply chain risks, including the purchase of a sufficient supply of critical components incorporated into its product offerings;
risks relating to AOI’s operations and business, including information technology and cybersecurity risks, failure to adequately
forecast supply and demand, loss of key customers and deterioration in relationships between AOI and its employees; AOI’s ability
to successfully collaborate with business partners; demand for AOI’s current and future offerings; risks that orders that have
been placed for AOI’s products are cancelled or modified; risks related to increased competition; risks relating to potential disruption
in the transportation and shipping infrastructure, including trade policies and export controls; risks that AOI is unable to secure or
protect its intellectual property; risks of product liability or regulatory lawsuits relating to AOI’s products and services; risks
that the post-combination company experiences difficulties managing its growth and expanding operations; the uncertain effects of the
COVID-19 pandemic and certain geopolitical developments; the inability of the parties to successfully or timely consummate the proposed
Business Combination, including the risk that any required shareholder or regulatory approvals are not obtained, are delayed or are subject
to unanticipated conditions that could adversely affect the combined company or the expected benefits of the proposed Business Combination;
the outcome of any legal proceedings that may be instituted against AOI, Edoc or Pubco or other following announcement of the proposed
Business Combination and transactions contemplated thereby; the ability of AOI to execute its business model, including market acceptance
of its planned products and services and achieving sufficient production volumes at acceptable quality levels and prices; technological
improvements by AOI’s peers and competitors; and those risk factors discussed in documents of Pubco and Edoc filed, or to be filed,
with the Securities and Exchange Commission (the “SEC”). If any of these risks materialize or our assumptions prove
incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional
risks that neither Edoc nor AOI presently know or that Edoc and AOI currently believe are immaterial that could also cause actual results
to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Edoc’s and AOI’s
expectations, plans or forecasts of future events and views as of the date of this report. Edoc and AOI anticipate that subsequent events
and developments will cause Edoc’s and AOI’s assessments to change. However, while Edoc and AOI may elect to update these
forward-looking statements at some point in the future, Edoc and AOI specifically disclaim any obligation to do so. Readers are referred
to the most recent reports filed with the SEC by Edoc. Readers are cautioned not to place undue reliance upon any forward-looking statements,
which speak only as of the date made, and we undertake no obligation to update or revise the forward-looking statements, whether as a
result of new information, future events or otherwise.
Additional
Information
Pubco
filed with the SEC on September 18, 2023, a Registration Statement on Form F-4 (as may be amended, the “Registration Statement”),
which includes a preliminary proxy statement of Edoc and a prospectus in connection with the proposed Business Combination involving
Edoc, Pubco, American Physicians LLC, AOI Merger Sub, Gary Seaton, and the holders of AOI’s outstanding capital shares named on
Annex I of the Business Combination Agreement. The definitive proxy statement and other relevant documents will be mailed to shareholders
of Edoc as of a record date to be established for voting on Edoc’s proposed Business Combination with AOI. SHAREHOLDERS OF EDOC
AND OTHER INTERESTED PARTIES ARE URGED TO READ, WHEN AVAILABLE, THE PRELIMINARY PROXY STATEMENT, AND AMENDMENTS THERETO, AND THE DEFINITIVE
PROXY STATEMENT IN CONNECTION WITH EDOC’S SOLICITATION OF PROXIES FOR THE SPECIAL MEETING OF ITS SHAREHOLDERS TO BE HELD TO APPROVE
THE BUSINESS COMBINATION BECAUSE THESE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION ABOUT EDOC, AOI, PUBCO AND THE BUSINESS COMBINATION.
Shareholders will also be able to obtain copies of the Registration Statement and the proxy statement/prospectus, without charge, once
available, on the SEC’s website at www.sec.gov or by directing a request to: Edoc Acquisition Corp., 7612 Main Street Fishers,
Suite 200, Victor, NY 14564, Attention: Kevin Chen.
Participants
in the Business Combination
Pubco,
Edoc and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the shareholders
of Edoc in connection with the Business Combination. Information regarding the officers and directors of Edoc is set forth in Edoc’s
annual report on Form 10-K, which was filed with the SEC on January 24, 2023. Additional information regarding the interests of such
potential participants are included in the Registration Statement on Form F-4 (and will be included in the definitive proxy statement/prospectus
for the Business Combination) and other relevant documents filed with the SEC.
Disclaimer
This
communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale
of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification
under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the
requirements of Section 10 of the Securities Act of 1933, as amended.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
EDOC Acquisition Corp. |
| |
|
|
|
| Date: November 3, 2023 |
By: |
/s/ Kevin Chen |
| |
|
Name: |
Kevin Chen |
| |
|
Title: |
Chief Executive Officer |
4
Exhibit
10.1
ASSIGNMENT, ASSUMPTION
AND AMENDMENT AGREEMENT
(WARRANT AGREEMENT)
This ASSIGNMENT,
ASSUMPTION AND AMENDMENT AGREEMENT (this “Agreement”) is made as of October 27, 2023, by and among EDOC Acquisition
Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company,
a New York corporation (the “Warrant Agent”).
WHEREAS,
the Company and the Warrant Agent are parties to that certain Warrant Agreement, dated as of November 9, 2020 and filed by the Company
with the United States Securities and Exchange Commission on November 13, 2020 (the “Existing Warrant Agreement”);
WHEREAS,
the terms of the Warrants (as defined in the Existing Warrant Agreement) are governed by the Existing Warrant Agreement and capitalized
terms used herein, but not otherwise defined, shall have the meanings given to such terms in the Existing Warrant Agreement;
WHEREAS,
the Company entered into a Business Combination Agreement, dated as of December 5, 2022 (as amended on March 31, 2023,
and as may be further amended) (the “Business Combination Agreement”), by and among the Company, American Physicians
LLC, a Delaware limited liability company, in the capacity as the representative for the shareholders of the Company and Pubco (as defined
below) (other than the Sellers (as defined below)) in accordance with the terms and conditions of the Business Combination Agreement
(the “Purchaser Representative”), Australian Oilseeds
Holdings Limited, a Cayman Islands exempted company (“Pubco”), AOI Merger Sub, a Cayman Islands exempted company and
a wholly-owned subsidiary of Pubco (“Merger Sub”), Australian Oilseeds Investments Pty Ltd., ACN 158 999 949,
an Australian proprietary company (“AOI”), Gary Seaton, in his capacity as the representative for the Sellers (the
“Seller Representative”), and each of the holders of AOI’s outstanding ordinary shares named on Annex I to
the Business Combination Agreement (the “Primary Sellers”), as amended from time to time, to include subsequent parties
that execute and deliver to Purchaser, Pubco and AOI, a joinder (the “Joining Sellers”), and the holders of AOI’s
outstanding ordinary shares who are bound by the provisions of the Business Combination Agreement pursuant to the drag-along rights
set forth in AOI’s memorandum and articles of association (the “Drag-Along Sellers,” and collectively with
the Joining Sellers, the “Sellers”);
WHEREAS,
at the closing of the Business Combination Agreement, among other things (the “Closing”), (a) the Company will
merge with and into Merger Sub, with the Company continuing as the surviving entity (the “Merger”), as a result of
which, (i) the Company shall become a wholly-owned subsidiary of Pubco, and (ii) each issued and outstanding security of
the Company (the “Company Ordinary Shares”) immediately prior to the effective time shall no longer be outstanding
and shall automatically be cancelled, in exchange for the right of the holder thereof to receive substantially identical securities of
Pubco, and (b) Pubco will acquire all of the issued and outstanding ordinary shares of AOI (the “Purchased Shares”)
from the Sellers in exchange for ordinary shares of Pubco, par value $0.0001 per share (“Pubco Ordinary Shares”) (the
“Share Exchange”, and together with the Merger and the other transactions contemplated by the Business Combination
Agreement, the “Transactions” or the “Business Combination”), all upon the terms and subject to
the conditions set forth in the Business Combination Agreement;
WHEREAS,
upon consummation of the Merger, as provided in Section 4.5 of the Existing Warrant Agreement, the Warrants will no longer be exercisable
for Company Ordinary Shares, but instead will be exercisable (subject to the terms and conditions of the Existing Warrant Agreement as
amended hereby) for a like number of Pubco Ordinary Shares;
WHEREAS,
the consummation of the transactions contemplated by the Business Combination Agreement will constitute a Business Combination (as
defined in the Existing Warrant Agreement);
WHEREAS,
in connection with the Merger, the Company desires to assign all of its right, title and interest in the Existing Warrant Agreement to
Pubco; and
WHEREAS,
Section 9.8 of the Existing Warrant Agreement provides that the Company and the Warrant Agent may amend the Existing Warrant Agreement
without the consent of any Registered Holders (as defined in the Existing Warrant Agreement) (i) for the purpose, among other things,
of adding or changing any other provisions with respect to matters or questions arising under the Existing Warrant Agreement as the Company
and the Warrant Agent may deem necessary or desirable and that the Company and the Warrant Agent deem shall not adversely affect the interest
of the registered holders under the Existing Warrant Agreement; and (ii) to provide for the delivery of securities pursuant to Section
4.5 of the Existing Warrant Agreement.
NOW, THEREFORE,
in consideration of the mutual agreements contained herein and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereto agree as follows.
1. Assignment and Assumption; Consent.
1.1 Assignment
and Assumption. The Company hereby assigns to Pubco all of the Company’s right, title and interest in and to the Existing Warrant
Agreement (as amended hereby) as of the Merger Effective Time (as defined in the Business Combination Agreement). Pubco hereby assumes,
and agrees to pay, perform, satisfy and discharge in full, as the same become due, all of the Company’s liabilities and obligations
under the Existing Warrant Agreement (as amended hereby) arising from and after the Merger Effective Time.
1.2 Consent.
The Warrant Agent hereby consents to the assignment of the Existing Warrant Agreement by the Company to Pubco pursuant to Section 1.1
hereof effective as of the Merger Effective Time, and the assumption of the Existing Warrant Agreement by Pubco from the Company pursuant
to Section 1.1 hereof effective as of the Merger Effective Time, and to the continuation of the Existing Warrant Agreement in full
force and effect from and after the Merger Effective Time, subject at all times to the Existing Warrant Agreement (as amended hereby)
and to all of the provisions, covenants, agreements, terms and conditions of the Existing Warrant Agreement and this Agreement.
2. Amendment
of Existing Warrant Agreement. The Company and the Warrant Agent hereby amend the Existing Warrant Agreement as provided
in this Section 2, effective as of the Merger Effective Time, and acknowledge and agree that the amendments to the Existing Warrant
Agreement set forth in this Section 2 (i) are necessary or desirable and that such amendments do not adversely affect the interests
of the registered holders under the Existing Warrant Agreement, and (ii) are to provide for the delivery of securities pursuant to Section
4.5 of the Existing Warrant Agreement (in connection with the Merger and the transactions contemplated by the Business Combination Agreement):
2.1 Preamble;
References to the “Company”. The preamble on page one of the Existing Warrant Agreement is hereby amended by deleting
“EDOC Acquisition Corp., a Cayman Islands exempted company” and replacing it with “Australian Oilseeds Holdings
Limited, a Cayman Islands exempted company” As a result thereof, all references to the “Company” in the Existing Warrant
Agreement shall be references to Australian Oilseeds Holdings Limited rather than EDOC Acquisition Corp.
2.2 References
to “Ordinary Shares”. All references to “Ordinary Shares” in the Existing Warrant Agreement (including all
Exhibits thereto) shall be references to Pubco Ordinary Shares.
2.3 References
to “Business Combination”. All references to the “Business Combination” in the Existing Warrant
Agreement (including all Exhibits thereto) shall be references to the transactions contemplated by the Business Combination
Agreement, and references to “the closing of the Business Combination” and all variations thereof in the Existing
Warrant Agreement (including all Exhibits thereto) shall be references to the effective time of the Merger.
2.4 Notices.
Section 9.2 of the Existing Warrant Agreement is hereby deleted and replaced with the following:
“Any notice,
statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the
Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier
service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the
Company with the Warrant Agent), as follows:
Australian Oilseeds Holdings Limited
126 – 142 Cowcumbla Street, Cootamundra
Site 2: 52 Fuller Drive Cootamundra
PO Box 263 Cootamundra, Australia 2590
Tel.: 02 6942 4347
Email: gary@energreennutrition.com.au
Any notice, statement
or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall
be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within
five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent
with the Company), as follows:
Continental
Stock Transfer & Trust Company One State Street, 30th Floor
New York, NY 10004
Attention:
Compliance Department
in each
case, with copies to:
Rimon P.C.
1909 K. Street
NW, Suite 402
Washington
DC 20006
Attn: Debbie
A. Klis
Email: debbie.klis@rimonlaw.com
and
Arent Fox Schiff LLP
1717 K Street NW
Washington, D.C. 20006
Attn: Ralph V. De Martino, Esq
2.5 Applicable
Law. Section 9.3 of the Existing Warrant Agreement is hereby amended by adding the following after the last sentence:
“The
foregoing provisions of this Section 9.3 will not apply to suits brought to enforce any liability or duty created by the Exchange
Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum. Section
27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange
Act or the rules and regulations thereunder.”
3. Miscellaneous Provisions.
3.1 Effectiveness.
Each of the parties hereto acknowledges and agrees that the effectiveness of this Agreement shall be expressly subject to the occurrence
of the Merger and shall automatically be terminated and shall be null and void if the Business Combination Agreement shall be terminated
for any reason.
3.2 Successors.
All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the
benefit of their permitted respective successors and assigns.
3.3 Severability.
This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the
validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable
term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to
such invalid or unenforceable provision as may be possible and be valid and enforceable.
3.4 Applicable
Law. The validity, interpretation and performance of this Agreement shall be governed in all respects by the laws of the State of
New York, without giving effect to conflict of laws. The parties hereby agree that any action, proceeding or claim against it arising
out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States
District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive.
Each of the parties hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum.
3.5 Counterparts.
This Agreement may be executed in any number of counterparts, and by facsimile or portable document format (pdf) transmission, and each
of such counterparts shall for all purposes be deemed to be an original and all such counterparts shall together constitute but one and
the same instrument.
3.6 Effect of
Headings; Interpretation. The Section headings herein are for convenience only and are not part of this Agreement and shall
not affect the interpretation thereof. All references to “dollars” or”$” refer to currency of the United States
of America.
3.7 Entire
Agreement. The Existing Warrant Agreement, as modified by this Agreement, constitutes the entire understanding of the parties and
supersedes all prior agreements, understandings, arrangements, promises and commitments, whether written or oral, express or implied,
relating to the subject matter hereof, and all such prior agreements, understandings, arrangements, promises and commitments are hereby
canceled and terminated.
[Remainder of page intentionally
left blank.}
IN WITNESS
WHEREOF, each of the parties has caused this Agreement to be duly executed as of the date first above written.
| |
EDOC ACQUISITION CORP. |
| |
|
|
| |
By: |
/s/ Kevin Chen |
| |
By: |
Kevin Chen |
| |
Title: |
Chief Executive Officer |
| |
|
|
| |
AUSTRALIAN OILSEEDS HOLDINGS LIMITED |
| |
|
|
| |
By: |
/s/ Gary Seaton |
| |
By: |
Gary Seaton |
| |
Title: |
Chief Executive Officer |
| |
|
|
| |
CONTINENTAL STOCK TRANSFER & TRUST COMPANY |
| |
|
|
| |
By: |
/s/ Luis Ortiz |
| |
By: |
Luis Ortiz |
| |
Title: |
Vice President |
[Signature Page to Assignment, Assumption
and Amendment Agreement]
Edoc Acquisition (NASDAQ:ADOC)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Edoc Acquisition (NASDAQ:ADOC)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
